Market outlook of the clinical immunoassay analyzer market in the US

Technavio’s market research analyst predicts the clinical immunoassay analyzer market in the US to grow at a healthy CAGR of around 6% during the forecast period. The patients’ growing demand for high-throughput screening with the aid of immunoassays is a significant factor that augments growth in this market during the forecast period.

In this market research report, analysts estimate eminent factors, such as the rising demand for next-generation immunodiagnostics, to drive market growth during the forecast period. These immunodiagnostic devices address the needs of modern clinical laboratories and provide high quality, reliable test results for patients and clinicians. The ability of such devices to improve the workflow and turnaround time for tests is envisaged to impel market growth during the forecast period.

Clinical immunoassay analyzer market:  Competitive landscape and key vendors

This market is characterized by the presence of intense competition among several large, medium, and small-sized manufacturers. These vendors form partnerships and provide premium-priced products to maintain their market share. However, since the local vendors in this market offer products at lower prices, they can be a serious threat to large companies.

Some of the leading vendors in the clinical immunoassay analyzer market

• Abbott Diagnostics
• Beckman Coulter
• bioMerieux
• Roche Diagnostics
• Siemens Healthcare Diagnostic

Clinical immunoassay analyzer market based on application

• Oncology and Endocrinology
• Hepatitis and Retrovirus testing
• Infectious disease testing
• GI stool testing

The oncology and endocrinology segment is estimated to be the fastest-growing market segment during the forecast period. This segment is envisaged to exhibit an impressive market growth rate of nearly 7% by 2020, and factors like the high popularity of immunoassay analyzers due to their compact size and cost-efficiency are expected to further impel market growth during the predicted period.

Clinical immunoassay analyzer market by-product

• Instruments
• Services and spare parts

In this market research report, analysts have estimated the instruments segment to account for more than 75% of the total market share by 2020. Much of this segment’s growth can be attributed to the high popularity of instruments, such as immunoassay analyzers, in hospitals and clinical laboratories for automated biochemical testing.

Want a bigger picture? Try a FREE sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.  

Key questions answered in the report include

• What will the market size and the growth rate be in 2020?
• What are the key factors driving the clinical immunoassay analyzer market in the US?
• What are the key market trends impacting the growth of the clinical immunoassay analyzer market in the US?
• What are the challenges to market growth?
• Who are the key vendors in the clinical immunoassay analyzer market in the US?
• What are the market opportunities and threats faced by the vendors in the clinical immunoassay analyzer market in the US?
• What are the key outcomes of the five forces analysis of the clinical immunoassay analyzer market in the US?

Get more value with Technavio’s subscription platform! Gain easy access to all of Technavio’s reports, along with on-demand services. Start your 14-day FREE trial

Technavio also provides customized reports based on the specific requirement of our clients.

Related reports

• Global Immunodiagnostics Market 2015-2019
• Immunodiagnostic Market in China 2015-2019